Tara Kervin, MPH
Chief Strategy Officer | Managing Director, U.S.
Tara Kervin leads the development and execution of IDDI’s corporate strategy, helping to ensure the company continues to advance clinical data science while responding to the evolving needs of sponsors and the wider clinical research industry. As Managing Director, U.S., she also provides leadership for IDDI’s U.S. operations.
With more than 15 years of experience in clinical research, Tara brings a multidisciplinary perspective spanning clinical trial operations, biostatistics, public health, and strategic leadership. Her expertise includes independent data and safety monitoring, project and business management, advanced data analysis, and strategic statistical and regulatory consulting.
Since joining IDDI in 2022, Tara has played a central role in shaping the company’s U.S. presence and global operations. In her role as Chief Strategy Officer, she works across the organization to translate IDDI’s scientific expertise into strategic priorities that strengthen its impact for customers and clinical research. Tara works closely with researchers to bridge the scientific, operational, and commercial challenges sponsors face when advancing novel therapies.
Prior to joining IDDI in 2022, Tara was the Director of Operations at Statistics Collaborative and a staff member at The George Washington University school of Public Health.
